SCHEMBL2228864

SCHEMBL2228864

CC(O)Oc1ccccc1C(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.55
ABCB1 P08183 7/20 0.51
IRAK4 Q9NWZ3 1/20 0.49
AKR1C3 P42330 1/20 0.48
BCL2 P10415 1/20 0.47
MCL1 Q07820 1/20 0.47
MAPT P10636 5/20 0.46
MAPK1 P28482 2/20 0.46
GAA P10253 1/20 0.46
KDM4E B2RXH2 3/20 0.45
HSD17B10 Q99714 3/20 0.45
ALOX15 P16050 1/20 0.45
DRD2 P14416 1/20 0.44
DRD1 P21728 1/20 0.44
DRD3 P35462 1/20 0.44
HPGD P15428 2/20 0.44
LMNA P02545 1/20 0.44
CYP3A4 P08684 1/20 0.44
RECQL P46063 1/20 0.44
ALDH1A1 P00352 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL21549818 0.97 ELANE (0.53) ELANEABCB1IRAK4AKR1C3BCL2
SCHEMBL27694472 0.88 IRAK4 (0.64) ELANEABCB1IRAK4AKR1C3BCL2
SCHEMBL21549820 0.87 ELANE (0.50) ELANEABCB1IRAK4AKR1C3BCL2
SCHEMBL770171 0.86 ELANE (0.54) ELANEABCB1AKR1C3MAPTMAPK1
SCHEMBL31602130 0.86 ELANE (0.54) ELANEABCB1AKR1C3MAPTMAPK1
SCHEMBL11402308 0.85 KMT2A (0.60) ELANEABCB1IRAK4AKR1C3BCL2
SCHEMBL1256752 0.85 ELANE (0.54) ELANEABCB1IRAK4AKR1C3BCL2
Acetic Acid SCHEMBL21549817 0.85 ELANE (0.48) ELANEABCB1IRAK4AKR1C3BCL2
SCHEMBL2299380 0.84 ELANE (0.53) ELANEABCB1AKR1C3MAPTMAPK1
SCHEMBL2299376 0.84 ELANE (0.53) ELANEABCB1AKR1C3MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090061340-A1 HYDROXY BENZOPHENONE CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-03-05 US claimed
CN-111417379-B Liquid enhancing cosmetic composition 地一生物有限公司 2023-09-22 CN disclosed
US-20200262777-A1 METHOD FOR PREPARING HYDROXYBENZOPHENONE POLYGLYCOL ETHER (METH)ACRYLATE BASF SE (DE) 2020-08-20 US disclosed
CN-111417379-A Liquid enhanced cosmetic composition 地一生物有限公司 2020-07-14 CN disclosed
EP-3390338-A1 METHOD FOR PRODUCING HYDROXYBENZOPHENONE POLYGLYCOL ETHER (METH)ACRYLATE BASF SE (DE) 2018-10-24 EP disclosed
WO-2017102675-A1 METHOD FOR PRODUCING HYDROXYBENZOPHENONE POLYGLYCOL ETHER (METH)ACRYLATE BASF SE (DE) 2017-06-22 WO disclosed
US-9085519-B2 Processes for producing benzophenone derivatives CAMBREX KARLSKOGA AB (SE) 2015-07-21 US disclosed
EP-2526080-B1 NEW PROCESSES FOR PRODUCING BENZOPHENONE DERIVATIVES CAMBREX KARLSKOGA AB (SE) 2014-03-26 EP disclosed
US-20130035514-A1 NEW PROCESSES FOR PRODUCING BENZOPHENONE DERIVATIVES CAMBREX KARLSKOGA AB (SE) 2013-02-07 US disclosed
EP-2526080-A1 NEW PROCESSES FOR PRODUCING BENZOPHENONE DERIVATIVES Cambrex Karlskoga AB (SE) 2012-11-28 EP disclosed
WO-2011089385-A1 NEW PROCESSES FOR PRODUCING BENZOPHENONE DERIVATIVES CAMBREX KARLSKOGA AB (SE) 2011-07-28 WO disclosed
US-5206417-A Carbamylbensophenone or -acetophenone derivatives containing (meth)acryloyloxy-alkyl group BASF AKTIENGESELLSCHAFT (DE) 1993-04-27 US disclosed
EP-0346788-B1 RADIATION-SENSITIVE ETHYLENICALLY UNSATURATED COPOLYMERIZABLE COMPOUNDS AND PROCESS FOR THEIR PREPARATION BASF Aktiengesellschaft (DE) 1992-04-08 EP disclosed
EP-0346788-A1 Radiation-sensitive ethylenically unsaturated copolymerizable compounds and process for their preparation BASF Aktiengesellschaft (DE) 1989-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035514-A1 NEW PROCESSES FOR PRODUCING BENZOPHENONE DERIVATIVES CYP1B1, CYP4B1, CYP2B6 ELANE 2780/4885ABCB1 178/4885IRAK4 1919/4885
US-20200262777-A1 METHOD FOR PREPARING HYDROXYBENZOPHENONE POLYGLYCOL ETHER (METH)ACRYLATE GRHPR, AGL, PAM ELANE 2474/4885ABCB1 2021/4885IRAK4 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.